.svg){kind=small}
Market Insights Snapshot
In June 2026, Cannavore’s mix was concentrated entirely in Edible, with Edible holding a 100.0% share and a category rank of 8 in Nevada. Within that single-category focus, Edible sales were up 5,130.9% year over year while declining 20.3% month over month, and brand-wide year-over-year growth of 4,080.7% paired with a 9.8% average price increase indicates the lift was volume-led more than price-led. The implication is that Cannavore’s scale-up is occurring inside one format where it already has mid‑tier placement (rank 8), and the recent month-over-month pullback suggests volatility typical of a rapid share build rather than a broad-based retreat.
The combination of a 100.0% category concentration and a rank of 8 in Nevada positions Cannavore as a specialist rather than a portfolio balancer, with June 2026 dynamics pointing to depth over breadth. A 5,130.9% year-over-year surge alongside a 20.3% month-over-month dip implies that brand equity and trial are expanding faster than repeat in Edible, and the 9.8% average price increase without diversification risk elevates price elasticity exposure in a single battleground. The net takeaway is that maintaining rank momentum within Edible while smoothing month-to-month swings will matter more to Cannavore’s trajectory than near-term category expansion, because concentrated gains can compound quickly but are sensitive to short-cycle demand shifts.
Competitive Landscape
Cannavore is ranked #8 in NV Edible in June 2026, improving 30 positions from #38 year over year, and it also inched up 1 rank from #9 in March 2026 while peaking at #6 in April 2026; the mix of a 2-rank pullback from April 2026 to June 2026 and a 30-rank YoY climb signals rapid recovery with near-term consolidation. Against competitors, Wyld held #1 both year over year and in June 2026 despite a -1.9% YoY sales change, while Kanha / Sunderstorm advanced from #9 to #3 on a 191.2% YoY sales increase; this contrast indicates Cannavore’s rank gains are driven more by share recapture than outsized category growth. The pattern implies Cannavore’s trajectory is upward on a yearly basis but capped near the mid–top tier in the short run unless it converts April 2026’s #6 peak into sustained top-5 presence.
Notable Products
CBN/THC 2:1 Grape Lemonade Gummies 10-Pack (200mg CBN, 100mg THC) posted the steepest decline in June 2026 at -71.5% and slid to rank 7, while the flagship CBD/THC 3:1 Cherry Pineapple Gummies 10-Pack (300mg CBD, 100mg THC) also fell -13.1% but held rank 1. CBD/CBN/THC 1:1:1 Melon Medley Gummies 10-Pack (100mg CBD, 100mg CBN, 100mg THC) dropped -32.6% to rank 2, as the broader lineup saw six of the top ten concentrated in CBN- or CBG-blended formulations that mostly declined by double digits. With only one raw sales anchor at $54,520 for the leader and modest MoM gains of +8.4% to +18.0% limited to CBG-led SKUs at ranks 3 and 8, the mix is tilting away from heavy CBN emphasis toward balanced or CBG-forward options. This pattern implies Cannavore’s commercial direction is shifting from sleep-oriented CBN blends to daytime functional blends where sustained rank stability and smaller drawdowns offer a more dependable base.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
